LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 16.07 | 21.74 | 3 | 597 | 0.0050 | -0.3391 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 16.07 | 21.74 | 1079 | 597 | 1.8048 | 1.2629 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 18.04 | 21.74 | 274 | 750 | 0.3651 | 0.6420 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 18.04 | 21.74 | 958 | 750 | 1.2764 | 1.0978 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 18.04 | 21.74 | 4 | 750 | 0.0053 | -0.2820 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 18.04 | 21.74 | 1123 | 750 | 1.4962 | 1.1641 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 20.01 | 21.74 | 389 | 901 | 0.4313 | 0.7103 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 20.01 | 21.74 | 969 | 901 | 1.0744 | 1.0269 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 20.01 | 21.74 | 2 | 901 | 0.0022 | -0.3585 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 20.01 | 21.74 | 1149 | 901 | 1.2739 | 1.0922 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 21.98 | 21.74 | 571 | 1108 | 0.5152 | 0.7793 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 21.98 | 21.74 | 972 | 1108 | 0.8770 | 0.9542 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 21.98 | 21.74 | 4 | 1108 | 0.0036 | -0.2580 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 21.98 | 21.74 | 1151 | 1108 | 1.0385 | 1.0134 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 23.95 | 21.74 | 818 | 1354 | 0.6039 | 0.8378 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 23.95 | 21.74 | 978 | 1354 | 0.7220 | 0.8937 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 23.95 | 21.74 | 6 | 1354 | 0.0044 | -0.1942 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 23.95 | 21.74 | 1138 | 1354 | 0.8401 | 0.9424 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 25.92 | 21.74 | 879 | 1515 | 0.5800 | 0.8297 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 25.92 | 21.74 | 979 | 1515 | 0.6459 | 0.8622 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 25.92 | 21.74 | 10 | 1515 | 0.0066 | -0.1191 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 25.92 | 21.74 | 1162 | 1515 | 0.7667 | 0.9151 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.89 | 21.74 | 907 | 1677 | 0.5409 | 0.8132 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.89 | 21.74 | 977 | 1677 | 0.5826 | 0.8349 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.89 | 21.74 | 11 | 1677 | 0.0066 | -0.1030 | MN20160310_N01 | L22 |